Drug recall · April 12, 2023
Alprazolam Tab recall
Why: CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL. Ins:NDC 68788-7594-3
- Lots / codes
Lot: G1822K, Exp. Date:5/31/2023.
- Quantity
- 30 Bottles
- Company
- Preferred Pharmaceuticals, Inc., Anaheim, CA
- Distribution
- Nationwide in the USA
- Initiated
- March 27, 2023 · Voluntary: Firm initiated
- Classified
- April 5, 2023
- Reported
- April 12, 2023
- Ended
- October 24, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Alprazolam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.